Skip to content
Study details
Enrolling now

COPE-AKI Trial

University of Pittsburgh
NCT IDNCT05805709ClinicalTrials.gov data as of Apr 2026
Target enrollment

2,145

Study length

about 3.5 years

Ages

18+

Locations

9 sites in AL, CT, FL +3

What this study is about

This trial is testing a new way of caring for patients who have acute kidney injury in the hospital. The goal is to see if this approach helps people go home sooner and stay healthy longer after being hospitalized. This involves nurses, patient education, pharmacists, and doctors working together as a team.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Nurse Navigator
  • 2.Patient Education
  • 3.Pharmacist
  • +1 more

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Change from baseline in AKI-Specific Health-Related Quality of Life (HR-QoL) at 180 days., Change from baseline in Global Health-Related Quality of Life (HR-QoL) at 180 days., Change from baseline in Interactions with Providers at 180 days., Change from baseline in Social Support at 180 days., Recurrent Acute Kidney Injury (AKI) Hospitalization at 180 days

Body systems

Renal